(BUD) Anheuser Busch Inbev - Ratings and Ratios
Exchange: NYSE •
Country: Belgium •
Currency: USD •
Type: Common Stock •
ISIN: US03524A1088
Beer, Spirits, Canned, Non-Alcoholic
Dividends
| Dividend Yield | 1.96% |
| Yield on Cost 5y | 1.90% |
| Yield CAGR 5y | 11.62% |
| Payout Consistency | 89.8% |
| Payout Ratio | 34.2% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 22.0% |
| Value at Risk 5%th | 33.7% |
| Relative Tail Risk | -6.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.81 |
| Alpha | 15.86 |
| CAGR/Max DD | 0.12 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.545 |
| Beta | 0.255 |
| Beta Downside | 0.152 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.55% |
| Mean DD | 9.80% |
| Median DD | 9.17% |
Description: BUD Anheuser Busch Inbev December 02, 2025
Anheuser-Busch InBev (NYSE:BUD) is a global brewer headquartered in Leuven, Belgium, with a portfolio of roughly 500 brands-including Budweiser, Corona Extra, Stella Artois, and Michelob Ultra-sold across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. The company also markets spirits-based ready-to-drink and non-alcoholic beverages.
Key metrics as of FY 2023: revenue of $57 billion, adjusted EBITDA margin of 18 %, and net debt-to-EBITDA of 3.2×, reflecting a balance-sheet still leveraged after the 2022-23 debt-reduction program. Growth is being driven by premiumization (e.g., higher-margin craft and imported brands), a 7 % increase in on-trade volume in emerging markets, and a 4 % rise in e-commerce sales of RTD products, while commodity price volatility and shifting consumer preferences toward low-alcohol options remain material risks.
For a deeper, data-rich analysis of BUD’s valuation dynamics, you might explore the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (8.17b TTM) > 0 and > 6% of Revenue (6% = 4.42b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -3.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -13.67% (prev -39.36%; Δ 25.70pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 15.20b > Net Income 8.17b (YES >=105%, WARN >=100%) |
| Net Debt (61.00b) to EBITDA (19.70b) ratio: 3.10 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.70 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.99b) change vs 12m ago -2.79% (target <= -2.0% for YES) |
| Gross Margin 55.84% (prev 45.83%; Δ 10.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 34.58% (prev 34.18%; Δ 0.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.71 (EBITDA TTM 19.70b / Interest Expense TTM 6.56b) >= 6 (WARN >= 3) |
Altman Z'' 1.49
| (A) -0.05 = (Total Current Assets 23.00b - Total Current Liabilities 33.07b) / Total Assets 206.64b |
| (B) 0.23 = Retained Earnings (Balance) 46.58b / Total Assets 206.64b |
| (C) 0.05 = EBIT TTM 11.23b / Avg Total Assets 212.99b |
| (D) 0.68 = Book Value of Equity 80.67b / Total Liabilities 117.94b |
| Total Rating: 1.49 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.50
| 1. Piotroski 4.50pt |
| 2. FCF Yield 6.39% |
| 3. FCF Margin 15.83% |
| 4. Debt/Equity 0.79 |
| 5. Debt/Ebitda 3.10 |
| 6. ROIC - WACC (= 0.41)% |
| 7. RoE 9.64% |
| 8. Rev. Trend -31.05% |
| 9. EPS Trend 51.26% |
What is the price of BUD shares?
As of December 13, 2025, the stock is trading at USD 63.74 with a total of 1,946,639 shares traded.
Over the past week, the price has changed by +4.22%, over one month by -1.06%, over three months by +9.44% and over the past year by +21.45%.
Over the past week, the price has changed by +4.22%, over one month by -1.06%, over three months by +9.44% and over the past year by +21.45%.
Is BUD a buy, sell or hold?
Anheuser Busch Inbev has received a consensus analysts rating of 4.15.
Therefore, it is recommended to buy BUD.
- Strong Buy: 5
- Buy: 5
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BUD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.9 | 20.6% |
| Analysts Target Price | 76.9 | 20.6% |
| ValueRay Target Price | 66.4 | 4.2% |
BUD Fundamental Data Overview December 11, 2025
Market Cap USD = 117.78b (117.78b USD * 1.0 USD.USD)
P/E Trailing = 20.0797
P/E Forward = 14.4509
P/S = 2.0097
P/B = 1.4599
P/EG = 1.212
Beta = 0.671
Revenue TTM = 73.65b USD
EBIT TTM = 11.23b USD
EBITDA TTM = 19.70b USD
Long Term Debt = 68.97b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.45b USD (from shortTermDebt, last fiscal year)
Debt = 72.17b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 61.00b USD (from netDebt column, last fiscal year)
Enterprise Value = 182.58b USD (117.78b + Debt 72.17b - CCE 7.37b)
Interest Coverage Ratio = 1.71 (Ebit TTM 11.23b / Interest Expense TTM 6.56b)
FCF Yield = 6.39% (FCF TTM 11.66b / Enterprise Value 182.58b)
FCF Margin = 15.83% (FCF TTM 11.66b / Revenue TTM 73.65b)
Net Margin = 11.09% (Net Income TTM 8.17b / Revenue TTM 73.65b)
Gross Margin = 55.84% ((Revenue TTM 73.65b - Cost of Revenue TTM 32.52b) / Revenue TTM)
Gross Margin QoQ = 56.41% (prev 56.29%)
Tobins Q-Ratio = 0.88 (Enterprise Value 182.58b / Total Assets 206.64b)
Interest Expense / Debt = 1.25% (Interest Expense 903.0m / Debt 72.17b)
Taxrate = 32.14% (726.0m / 2.26b)
NOPAT = 7.62b (EBIT 11.23b * (1 - 32.14%))
Current Ratio = 0.70 (Total Current Assets 23.00b / Total Current Liabilities 33.07b)
Debt / Equity = 0.79 (Debt 72.17b / totalStockholderEquity, last quarter 91.41b)
Debt / EBITDA = 3.10 (Net Debt 61.00b / EBITDA 19.70b)
Debt / FCF = 5.23 (Net Debt 61.00b / FCF TTM 11.66b)
Total Stockholder Equity = 84.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.95% (Net Income 8.17b / Total Assets 206.64b)
RoE = 9.64% (Net Income TTM 8.17b / Total Stockholder Equity 84.76b)
RoCE = 7.31% (EBIT 11.23b / Capital Employed (Equity 84.76b + L.T.Debt 68.97b))
RoIC = 5.05% (NOPAT 7.62b / Invested Capital 151.01b)
WACC = 4.64% (E(117.78b)/V(189.95b) * Re(6.96%) + D(72.17b)/V(189.95b) * Rd(1.25%) * (1-Tc(0.32)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.75%
[DCF Debug] Terminal Value 78.25% ; FCFE base≈15.20b ; Y1≈15.17b ; Y5≈16.01b
Fair Price DCF = 164.1 (DCF Value 283.40b / Shares Outstanding 1.73b; 5y FCF grow -0.88% → 3.0% )
EPS Correlation: 51.26 | EPS CAGR: 2.57% | SUE: 0.41 | # QB: 0
Revenue Correlation: -31.05 | Revenue CAGR: -15.51% | SUE: -0.10 | # QB: 0
EPS next Year (2026-12-31): EPS=4.19 | Chg30d=-0.014 | Revisions Net=+1 | Growth EPS=+12.5% | Growth Revenue=+5.3%
P/E Trailing = 20.0797
P/E Forward = 14.4509
P/S = 2.0097
P/B = 1.4599
P/EG = 1.212
Beta = 0.671
Revenue TTM = 73.65b USD
EBIT TTM = 11.23b USD
EBITDA TTM = 19.70b USD
Long Term Debt = 68.97b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.45b USD (from shortTermDebt, last fiscal year)
Debt = 72.17b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 61.00b USD (from netDebt column, last fiscal year)
Enterprise Value = 182.58b USD (117.78b + Debt 72.17b - CCE 7.37b)
Interest Coverage Ratio = 1.71 (Ebit TTM 11.23b / Interest Expense TTM 6.56b)
FCF Yield = 6.39% (FCF TTM 11.66b / Enterprise Value 182.58b)
FCF Margin = 15.83% (FCF TTM 11.66b / Revenue TTM 73.65b)
Net Margin = 11.09% (Net Income TTM 8.17b / Revenue TTM 73.65b)
Gross Margin = 55.84% ((Revenue TTM 73.65b - Cost of Revenue TTM 32.52b) / Revenue TTM)
Gross Margin QoQ = 56.41% (prev 56.29%)
Tobins Q-Ratio = 0.88 (Enterprise Value 182.58b / Total Assets 206.64b)
Interest Expense / Debt = 1.25% (Interest Expense 903.0m / Debt 72.17b)
Taxrate = 32.14% (726.0m / 2.26b)
NOPAT = 7.62b (EBIT 11.23b * (1 - 32.14%))
Current Ratio = 0.70 (Total Current Assets 23.00b / Total Current Liabilities 33.07b)
Debt / Equity = 0.79 (Debt 72.17b / totalStockholderEquity, last quarter 91.41b)
Debt / EBITDA = 3.10 (Net Debt 61.00b / EBITDA 19.70b)
Debt / FCF = 5.23 (Net Debt 61.00b / FCF TTM 11.66b)
Total Stockholder Equity = 84.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.95% (Net Income 8.17b / Total Assets 206.64b)
RoE = 9.64% (Net Income TTM 8.17b / Total Stockholder Equity 84.76b)
RoCE = 7.31% (EBIT 11.23b / Capital Employed (Equity 84.76b + L.T.Debt 68.97b))
RoIC = 5.05% (NOPAT 7.62b / Invested Capital 151.01b)
WACC = 4.64% (E(117.78b)/V(189.95b) * Re(6.96%) + D(72.17b)/V(189.95b) * Rd(1.25%) * (1-Tc(0.32)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.75%
[DCF Debug] Terminal Value 78.25% ; FCFE base≈15.20b ; Y1≈15.17b ; Y5≈16.01b
Fair Price DCF = 164.1 (DCF Value 283.40b / Shares Outstanding 1.73b; 5y FCF grow -0.88% → 3.0% )
EPS Correlation: 51.26 | EPS CAGR: 2.57% | SUE: 0.41 | # QB: 0
Revenue Correlation: -31.05 | Revenue CAGR: -15.51% | SUE: -0.10 | # QB: 0
EPS next Year (2026-12-31): EPS=4.19 | Chg30d=-0.014 | Revisions Net=+1 | Growth EPS=+12.5% | Growth Revenue=+5.3%
Additional Sources for BUD Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle